COMMUNIQUÉS West-GlobeNewswire

Media Conference - Update: Fightback to Save Durham Hospital Ratcheting Up

22/05/2024 - 21:47

TORONTO and GREY BRUCE, Ontario, May 22, 2024 (GLOBE NEWSWIRE) -- It is a small community, but it has raised its voice for the whole province to hear. Almost a thousand community members have taken to the streets in [...]

Bahrain Oncology Centre Amongst the First in the World to Offer Ground-breaking Sickle Cell and Transfusion Dependent Thalassemia Gene Therapy

22/05/2024 - 21:18

MUHARRAQ, Bahrain, May 22, 2024 (GLOBE NEWSWIRE) -- The Bahrain Oncology Centre (BOC) has achieved a significant milestone, becoming amongst the first centres in the World to offer the ground-breaking CASGEVY ( [...]

Virios Therapeutics Announces Closing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study

22/05/2024 - 19:30

ATLANTA, May 22, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company” or “Virios Therapeutics”), a development-stage biotechnology company focused on advancing novel antiviral therapies to [...]

ONWARD® Medical organise une téléconférence pour partager les détails relatifs à son étude clinique Up-LIFT et à sa publication dans la revue Nature Medicine

22/05/2024 - 19:13

La revue Nature Medicine a publié les résultats de l’essai clinique pivot Up-LIFT ONWARD Medical présentera les résultats de cet essai pivot à l’occasion d’une téléconférence organisée cette semaine avec le concours de [...]

SOHM, Inc., Targets Revolutionary New ABBIE Genome Editing Kits for Q3, 2024

22/05/2024 - 18:57

SOHM, Inc. Further Advances its Work in the Field of Genome Editing and ABBIE, a Retroviral Integrase with Linked Guided DNA Binding Domain CHINO HILLS, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. ( [...]

GENFIT: May 22, 2024 Combined Shareholders Meeting Results

22/05/2024 - 18:05

Quorum of 27.25% on first convening; allowing approval of all the resolutions Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 22, 2024 - GENFIT (Nasdaq and Euronext: GNFT) , a late- [...]

GENFIT : Résultats de l’Assemblée Générale Mixte du 22 mai 2024

22/05/2024 - 18:05

Quorum de 27,25% obtenu sur première convocation ayant permis d’approuver l’ensemble des projets de résolutions Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 22 mai 2024 – GENFIT (Nasdaq et [...]

Syapse Expands Oncology Real-World Data Offerings with Introduction of Syapse Cohorts: Essentials

22/05/2024 - 17:46

WEST CHESTER, Pa., May 22, 2024 (GLOBE NEWSWIRE) -- Syapse, a leading real-world oncology data company announced the launch of its latest real-world data offering: Syapse Cohorts: Essentials . This new offering expands [...]

Guerbet : NUCLIDIUM et Guerbet concluent un partenariat stratégique pour soutenir le développement de la radiothéranostique ciblée basée sur des radio-isotopes de cuivre.

22/05/2024 - 17:45

COMMUNIQUE DE PRESSE NUCLIDIUM et Guerbet concluent un partenariat stratégique pour soutenir le développement de la radiothéranostique ciblée basée sur des radio-isotopes de cuivre L'accord allie l'expertise de pointe [...]

Guerbet : NUCLIDIUM and Guerbet Form Strategic Partnership to Support the Advancement of targeted Copper-based Radiotheranostics.

22/05/2024 - 17:45

NUCLIDIUM and Guerbet Form Strategic Partnership to Support the Advancement of targeted Copper-based Radiotheranostics -- Agreement brings together Guerbet’s industry leading expertise in medical imaging technologies, [...]

Combined General Meeting of May 22, 2024

22/05/2024 - 17:45

Press Release Approval of all resolutions put forward by the Board of Directors, including the unconsolidated and consolidated financial statements for the year 2023 Ratification of the co-option of Géraldine Leveau as [...]

Assemblée Générale Mixte du 22 mai 2024

22/05/2024 - 17:45

Communiqué de presse Approbation de l’ensemble des résolutions agréées par le Conseil d’administration, y compris les comptes sociaux et les comptes consolidés de l’exercice 2023 Ratification de la cooptation de [...]

GrayHawk Health Appoints Maria McCall as Senior Vice President of Operations

22/05/2024 - 17:40

MALVERN, Pa., May 22, 2024 (GLOBE NEWSWIRE) -- GrayHawk Health, a Health Empowerment Organization, is pleased to announce the appointment of Maria McCall as its Senior Vice President of Operations. With a distinguished [...]

Kymera Therapeutics Presents New Preclinical Data for KT-621, a First-In-Class, Oral STAT6 Degrader at the ATS Annual Meeting

22/05/2024 - 17:20

KT-621, a potent, selective, oral STAT6 degrader, demonstrated comparable or superior activity to dupilumab in preclinical studies including an asthma model shared at the ATS Annual Meeting Additional KT-621 preclinical [...]

Upstream Bio Presents Results from a Dose Ranging Study of Verekitug (UPB-101) in Adults with Asthma at the American Thoracic Society International Conference

22/05/2024 - 17:15

– In a multiple-ascending dose (MAD) study in patients with asthma, up to 54% reduction in fractional exhaled nitric oxide concentration (F E NO) was observed with administration of verekitug, with treatment effects [...]

A Bold Step Forward: Trial Equity and Miller Tanner Associates Partner to Champion Diversity in Clinical Research

22/05/2024 - 16:23

PHILADELPHIA, May 22, 2024 (GLOBE NEWSWIRE) -- Trial Equity and Miller Tanner Associates (MTA) are excited to announce a groundbreaking partnership aimed at expanding education and participation across diverse patient [...]

HEALWELL AI Closes Upsized $20 Million Bought Deal Offering

22/05/2024 - 16:09

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, May 22, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI INC. (“ HEALWELL ” or the “ Company ”) (TSX: AIDX) is pleased to announce [...]

G1 Therapeutics to Participate in TD Cowen’s 5th Annual Oncology Innovation Summit

22/05/2024 - 16:00

RESEARCH TRIANGLE PARK, N.C., May 22, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that G1’s Chief Medical Officer Dr. Raj Malik and Chief [...]

GRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What This Means” Segment Highlighting Positive Preclinical Data from Idiopathic Pulmonary Fibrosis (IPF) and Systemic Lupus Erythematosus (SLE) Programs

22/05/2024 - 15:15

Data recently presented at the 2024 American Thoracic Society International Conference and the 14 th International Congress on Autoimmunity Company reiterates 2024 as year of data Click here to watch the “What This [...]